A significant discovery in cancer research is occurring with the use of VHH fragments to re-engage damaged p53. This vital cancer inhibitor protein is frequently disabled in several types of malignancies, resulting https://freebookmarkpost.com/story21789750/mini-antibodies-reactivate-the-p53-protein-new-promising-hope-for-malignant-treatment